nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Active surveillance of the spread of mcr-1-positive E coli
|
Wang, Shaolin |
|
|
|
1 |
p. e4-e5 |
artikel |
2 |
Africa's struggle with inadequate COVID-19 testing
|
Adepoju, Paul |
|
|
|
1 |
p. e12 |
artikel |
3 |
Approaches and challenges to inferring the geographical source of infectious disease outbreaks using genomic data
|
Chen, Zhiyuan |
|
|
|
1 |
p. e81-e92 |
artikel |
4 |
Assessing the daily natural history of asymptomatic Plasmodium infections in adults and older children in Katakwi, Uganda: a longitudinal cohort study
|
Hergott, Dianna E B |
|
|
|
1 |
p. e72-e80 |
artikel |
5 |
ASTMH 2023
|
Barksby, Rebecca |
|
|
|
1 |
p. e12 |
artikel |
6 |
Asymptomatic monkeypox infection: a call for greater control of infection and transmission
|
Reda, Abdullah |
|
|
|
1 |
p. e15-e16 |
artikel |
7 |
Bacterial nasopharyngeal colonisation in children in South Africa before and during the COVID-19 pandemic: an observational study
|
Olwagen, Courtney P |
|
|
|
1 |
p. e34-e42 |
artikel |
8 |
Bloodstream infections caused by Enterobacter hormaechei ST133 in China, 2010–22
|
Zhou, Kai |
|
|
|
1 |
p. e13 |
artikel |
9 |
Clinical relevance and plasmid dynamics of mcr-1-positive Escherichia coli in China: a multicentre case-control and molecular epidemiological study
|
Jiang, Yan |
|
|
|
1 |
p. e24-e33 |
artikel |
10 |
Co-infections: potentially lethal and unexplored in COVID-19
|
Cox, Michael J |
|
|
|
1 |
p. e11 |
artikel |
11 |
Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study
|
Chu, Hin |
|
|
|
1 |
p. e14-e23 |
artikel |
12 |
COP27 Climate Change Conference: urgent action needed for Africa and the world
|
Atwoli, Lukoye |
|
|
|
1 |
p. e6-e8 |
artikel |
13 |
Copy number variants of ERG11: mechanism of azole resistance in Candida parapsilosis
|
Ning, Yating |
|
|
|
1 |
p. e10 |
artikel |
14 |
Correction to Lancet Microbe 2022; 3: e701–10
|
|
|
|
|
1 |
p. e17 |
artikel |
15 |
Correction to Lancet Microbe 2021; published online Nov 16. https://doi.org/10.1016/S2666-5247(21)00211-1
|
|
|
|
|
1 |
p. e8 |
artikel |
16 |
Correction to Lancet Microbe 2021; published online Nov 11. https://doi.org/10.1016/S2666-5247(21)00277-9
|
|
|
|
|
1 |
p. e8 |
artikel |
17 |
Correction to Lancet Microbe 2021; published online Nov 23. https://doi.org/10.1016/S2666-5247(21)00209-3
|
|
|
|
|
1 |
p. e8 |
artikel |
18 |
COVID-19 vaccines: the pandemic will not end overnight
|
The Lancet Microbe, |
|
|
|
1 |
p. e1 |
artikel |
19 |
Current malaria infection, previous malaria exposure, and clinical profiles and outcomes of COVID-19 in a setting of high malaria transmission: an exploratory cohort study in Uganda
|
Achan, Jane |
|
|
|
1 |
p. e62-e71 |
artikel |
20 |
Defining access without excess: expanding appropriate use of antibiotics targeting multidrug-resistant organisms
|
Patel, Twisha S |
|
|
|
1 |
p. e93-e98 |
artikel |
21 |
Demographics of sources of HIV-1 transmission in Zambia: a molecular epidemiology analysis in the HPTN 071 PopART study
|
Hall, Matthew |
|
|
|
1 |
p. e62-e71 |
artikel |
22 |
Diphtheria outbreak in Nigeria
|
Balakrishnan, Vijay Shankar |
|
|
|
1 |
p. e11 |
artikel |
23 |
Direct diagnosis of Pasteurella multocida meningitis using next-generation sequencing
|
Morsli, M |
|
|
|
1 |
p. e6 |
artikel |
24 |
Disease outbreaks in Pakistan, Lebanon, and Syria
|
Venkatesan, Priya |
|
|
|
1 |
p. e18-e19 |
artikel |
25 |
Drug-resistant tuberculosis: the next sequence of events
|
The Lancet Microbe, |
|
|
|
1 |
p. e1 |
artikel |
26 |
Durability and cross-reactive immune memory to SARS-CoV-2 in individuals 2 years after recovery from COVID-19: a longitudinal cohort study
|
Guo, Li |
|
|
|
1 |
p. e24-e33 |
artikel |
27 |
Dynamics of mcr-1 prevalence and mcr-1-positive Escherichia coli after the cessation of colistin use as a feed additive for animals in China: a prospective cross-sectional and whole genome sequencing-based molecular epidemiological study
|
Shen, Cong |
|
|
|
1 |
p. e34-e43 |
artikel |
28 |
Estimating changes in antibiotic consumption in the USA with the introduction of doxycycline post-exposure prophylaxis
|
Roster, Kirstin I Oliveira |
|
|
|
1 |
p. e9 |
artikel |
29 |
From PREDICT to prevention, one pandemic later
|
Carlson, Colin J |
|
|
|
1 |
p. e6-e7 |
artikel |
30 |
Fungal infections in transplant recipients: pros and cons of immunosuppressive and antimicrobial treatment
|
Papon, Nicolas |
|
|
|
1 |
p. e6-e8 |
artikel |
31 |
Global distribution of human hookworm species and differences in their morbidity effects: a systematic review
|
Clements, Archie C A |
|
|
|
1 |
p. e72-e79 |
artikel |
32 |
Green light for improving our understanding of AMR spread
|
Kraychete, Gabriela B |
|
|
|
1 |
p. e2-e3 |
artikel |
33 |
Horizontal gene transfer and endogenous retroviruses as mechanisms for molecular mimicry
|
Parthasarathy, Rohit |
|
|
|
1 |
p. e4-e5 |
artikel |
34 |
Immune modulatory vaccines: time to move into infectious diseases
|
Andersen, Mads Hald |
|
|
|
1 |
p. e4-e5 |
artikel |
35 |
Increasing accessibility in COVID-19 clinical trials
|
Balakrishnan, Vijay Shankar |
|
|
|
1 |
p. e13 |
artikel |
36 |
Innovation in wastewater near-source tracking for rapid identification of COVID-19 in schools
|
Hassard, Francis |
|
|
|
1 |
p. e4-e5 |
artikel |
37 |
Interphylum dissemination of NDM-5-positive plasmids in hospital wastewater from Fuzhou, China: a single-centre, culture-independent, plasmid transmission study
|
Yang, Qiu E |
|
|
|
1 |
p. e13-e23 |
artikel |
38 |
Leaving no one behind: the need for a truly global response to antimicrobial resistance
|
Goldberg, Jacob |
|
|
|
1 |
p. e2-e3 |
artikel |
39 |
Leveraging an established neighbourhood-level, open access wastewater monitoring network to address public health priorities: a population-based study
|
Bowes, Devin A |
|
|
|
1 |
p. e29-e37 |
artikel |
40 |
Malaria progress stumbles, but new tools offer hope
|
The Lancet Microbe, |
|
|
|
1 |
p. e1 |
artikel |
41 |
Marburg virus outbreak in 2022: a public health concern
|
Araf, Yusha |
|
|
|
1 |
p. e9 |
artikel |
42 |
Molecular epidemiology and mortality of group B streptococcal meningitis and infant sepsis in the Netherlands: a 30-year nationwide surveillance study
|
van Kassel, Merel N |
|
|
|
1 |
p. e32-e40 |
artikel |
43 |
Monitoring monkeypox virus in saliva and air samples in Spain: a cross-sectional study
|
Hernaez, Bruno |
|
|
|
1 |
p. e21-e28 |
artikel |
44 |
Nasal host response-based screening for undiagnosed respiratory viruses: a pathogen surveillance and detection study
|
Cheemarla, Nagarjuna R |
|
|
|
1 |
p. e38-e46 |
artikel |
45 |
Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis
|
Cromer, Deborah |
|
|
|
1 |
p. e52-e61 |
artikel |
46 |
No collateral antibiotic sensitivity by alternating antibiotic pairs
|
Ma, Yeping |
|
|
|
1 |
p. e7 |
artikel |
47 |
Omicron-adapted vaccines might require longer follow-up to reveal true benefits
|
Tang, Lu |
|
|
|
1 |
p. e12 |
artikel |
48 |
Performance of clinical metagenomics in France: a prospective observational study
|
Fourgeaud, Jacques |
|
|
|
1 |
p. e52-e61 |
artikel |
49 |
Polio vaccination in Afghanistan
|
Bagcchi, Sanjeet |
|
|
|
1 |
p. e10 |
artikel |
50 |
Potential mechanisms of intrauterine transmission of monkeypox virus
|
Dashraath, Pradip |
|
|
|
1 |
p. e14 |
artikel |
51 |
Progress in tuberculosis vaccine research
|
Venkatesan, Priya |
|
|
|
1 |
p. e12 |
artikel |
52 |
Pyronaridine–artesunate or dihydroartemisinin–piperaquine combined with single low-dose primaquine to prevent Plasmodium falciparum malaria transmission in Ouélessébougou, Mali: a four-arm, single-blind, phase 2/3, randomised trial
|
Stone, William |
|
|
|
1 |
p. e41-e51 |
artikel |
53 |
Reduced sensitivity of antibody tests after omicron infection
|
Rössler, Annika |
|
|
|
1 |
p. e10-e11 |
artikel |
54 |
Role of the first WHO mutation catalogue in the diagnosis of antibiotic resistance in Mycobacterium tuberculosis in the Valencia Region, Spain: a retrospective genomic analysis
|
García-Marín, Ana María |
|
|
|
1 |
p. e43-e51 |
artikel |
55 |
Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trial
|
Bosaeed, Mohammad |
|
|
|
1 |
p. e11-e20 |
artikel |
56 |
SARS-CoV-2 cellular tropism
|
Cagno, Valeria |
|
|
|
1 |
p. e2-e3 |
artikel |
57 |
SARS-CoV-2 neutralising antibody response to bivalent booster after omicron infection
|
Springer, David N |
|
|
|
1 |
p. e8 |
artikel |
58 |
SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis
|
Cevik, Muge |
|
|
|
1 |
p. e13-e22 |
artikel |
59 |
Seroprevalence of chikungunya virus infection in India, 2017: a cross-sectional population-based serosurvey
|
Kumar, Muthusamy Santhosh |
|
|
|
1 |
p. e41-e47 |
artikel |
60 |
Severe breakthrough COVID-19 cases in the SARS-CoV-2 delta (B.1.617.2) variant era
|
Wang, Stephen Y |
|
|
|
1 |
p. e4-e5 |
artikel |
61 |
Solar ultraviolet radiation sensitivity of SARS-CoV-2
|
Seyer, Ayse |
|
|
|
1 |
p. e8-e9 |
artikel |
62 |
Stability of SARS-CoV-2 in different environmental conditions
|
Chin, Alex W H |
|
|
|
1 |
p. e10 |
artikel |
63 |
Start as we mean to go on
|
The Lancet Microbe, |
|
|
|
1 |
p. e1 |
artikel |
64 |
Strep A treatment, working for now
|
The Lancet Microbe, |
|
|
|
1 |
p. e1 |
artikel |
65 |
T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study
|
Angyal, Adrienn |
|
|
|
1 |
p. e21-e31 |
artikel |
66 |
The antibiotic subscription model: fostering innovation or repackaging old drugs?
|
Glover, Rebecca E |
|
|
|
1 |
p. e2-e3 |
artikel |
67 |
The current state of laboratory mycology and access to antifungal treatment in Europe: a European Confederation of Medical Mycology survey
|
Salmanton-García, Jon |
|
|
|
1 |
p. e47-e56 |
artikel |
68 |
The emerging role of Lactobacillus acidophilus in the cervicovaginal microenvironment
|
Molina, Mariano A |
|
|
|
1 |
p. e6-e7 |
artikel |
69 |
Viral interference cannot be concluded from datasets containing only symptomatic patients
|
Nordén, Rickard |
|
|
|
1 |
p. e9 |
artikel |
70 |
Viral interference cannot be concluded from datasets containing only symptomatic patients – Authors' reply
|
Wu, Anchi |
|
|
|
1 |
p. e10 |
artikel |
71 |
Virus persistence after recovery from acute Lassa fever in Nigeria: a 2-year interim analysis of a prospective longitudinal cohort study
|
Thielebein, Anke |
|
|
|
1 |
p. e32-e40 |
artikel |
72 |
WHO's Global Tuberculosis Report 2022
|
Bagcchi, Sanjeet |
|
|
|
1 |
p. e20 |
artikel |
73 |
WHO's 2021–30 roadmap for neglected tropical diseases
|
Balakrishnan, Vijay Shankar |
|
|
|
1 |
p. e11 |
artikel |
74 |
Worrying global decline in measles immunisation
|
Venkatesan, Priya |
|
|
|
1 |
p. e9 |
artikel |
75 |
Xenodiagnosis leads the way: elimination of visceral leishmaniasis from the Indian subcontinent is feasible and sustainable
|
Reithinger, Richard |
|
|
|
1 |
p. e2-e3 |
artikel |
76 |
Xenodiagnosis to evaluate the infectiousness of humans to sandflies in an area endemic for visceral leishmaniasis in Bihar, India: a transmission-dynamics study
|
Singh, Om Prakash |
|
|
|
1 |
p. e23-e31 |
artikel |